MEDdevice Acquisition Co., LLC Announces Board Members and Advisors

AURORA, Colo., /PRNewswire/ -- MEDdevice Acquisition Co., LLC MDAC is proud to announce that it has engaged a highly experienced team with deep domain experience and proven success optimizing investments in the medical device market as board members and advisors.

Epsilon Securities, LLC, to Provide M&A Advisory Services to MEDdevice Acquisition Co., LLC

AURORA, Colo., /PRNewswire/ -- MEDdevice Acquisition Corporation, LLC ("MDAC") is proud to announce that it has retained Epsilon Securities, LLC as M&A advisor in its focus to build a significant enterprise in one or more select medical device sectors of the medical device industry.

Patrick Gruber, CEO of Gevo, Inc. Receives George Washington Carver Award at BIO's World Congress

During a plenary lunch of the World Congress on Industrial Biotechnology and Bioprocessing, BIO presented the first annual George Washington Carver Award to Dr. Patrick Gruber, CEO, Gevo, Inc., recognizing his accomplishments in creating and commercializing a new plastic made from annually renewable resources.

Array BioPharma lands $80M investment

Array BioPharma Inc.said Monday the $80 million received from a large shareholder will help the company move six drug programs through clinical proof-of-concept studies.

OPX to commercialize CU technology

BOULDER - OPX Biotechnologies Inc. in Boulder has licensed technology from the University of Colorado's Technology Transfer Office that focuses on the production of biorefined fuels and chemicals.

ARCA Biopharma's new drug attacks heart disease

BROOMFIELD , CO - Personalized medicine, or the targeting of drugs to an individual's genetic makeup, is an emerging industry. Colorado-based ARCA Biopharma hopes to add an arrow to the quiver of available heart-disease therapies with one such genetically targeted treatment as early as next year.

MEDdevice Acquisition Co., LLC Engages Catalyst Financial Resources

DENVER, CO// MEDdevice Acquisition Corp., has selected Catalyst Financial Resources to execute a comprehensive investor awareness campaign aimed at increasing corporate visibility in the financial marketplace. Catalyst Financial Resources will initiate a program which includes investor conferences and institutional targeting to help promote the visibility of MEDdevice Acquisition Corp. in the financial marketplace. The contract involves extensive use of Catalyst’s proprietary process for creating, managing and developing institutional exposure to under-followed small & emerging companies.

Baxa Environmental Program Nets Significant Results

In celebration of Earth Day tomorrow, Baxa Corporation announces significant increase in environmental benefits through environmental stewardship and recycling programs.

Biologist with MBA working to bring drugs to market

Interview | A conversation with Rhonda Wallen, chief executive of Caveo Therapeutics, a Boulder-based biotechnology company

MONSANTO ANNOUNCES PLANNED EXPANSION AT ITS ROUNDUP FACILITY IN LULING, LOUISIANA

ST. LOUIS, April 2, 2008 — Monsanto announced today its intention to make an investment of up to $196 million over the next 18 months at its glyphosate manufacturing facility in Luling, Louisiana. The planned development will increase its global capacity to produce Roundup and other glyphosate-based herbicides.

R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007

Washington, D.C. (March 24, 2008) — America’s pharmaceutical and biotechnology research companies invested a record $58.8 billion last year in the research and development of new life-changing medicines and vaccines – an increase of nearly $3 billion from 2006, according to analyses by the Pharmaceutical Research and Manufacturers of America (PhRMA) and Burrill & Company.

OSI Pharmaceuticals, Inc. is Proud to be Re-Accredited in the CEO Cancer Gold Standard™ for 2008

The CEO Cancer Gold Standard™, calls for companies to evaluate their benefits and culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace.

Biopharma firm moving to Broomfield

BROOMFIELD - ARCA Discovery Inc., a Denver-based biopharmaceutical company, is moving its headquarters to Broomfield's new Arista mixed-use neighborhood.

Colorado State Vice President For Research Named Academy Of Toxicological Sciences Fellow

Fort Collins, Colorado - Bill Farland, vice president for Research at Colorado State University, has been named a Fellow of the Academy of Toxicological Sciences.

GlobeImmune Announces Initiation of a Phase 2a Clinical Trial of GI-4000 in Patients With Non-Small Cell Lung Cancer at Memorial Sloan Kettering

GlobeImmune, Inc. announced today the initiation of a Phase 2a clinical trial at Memorial Sloan Kettering Cancer Center (MSKCC) to evaluate GlobeImmune's GI-4000 Tarmogen(R) for the treatment of non-small cell lung cancer (NSCLC) patients with tumors having mutations in the ras gene.

Ventrus Biosciences

Greenwood Village, Colorado - Ventrus Biosciences, Inc., a specialty pharmaceutical company focused on the late-stage development and commercialization of gastrointestinal products, and Sam Amer & Company (Amer) today announced an agreement granting Ventrus exclusive world wide rights to develop and commercialize a Phase III novel topical ointment (VEN309) for the treatment of hemorrhoids.

Alphasniffer appoints board chairman

BOULDER - Alphasniffer LLC in Boulder, developers of a biosensor that detects trace amounts of biological and chemical agents, appointed Dr. J. William Freytag as chairman of its board of directors.

WayFarer creates 'visual representation' of thoughts

WayCrafts' product - the WayFarer - is a knowledge-management tool. It strives to create a visual representation of thought that is linked real time to sources of information. The WayFarer is a piece of software that requires input of data, sources, thoughts and diagrams that - through a graphic interface - can link to other databases and, at its highest level of functioning, manipulate that data to make predictions.

mBio developing device for medical diagnostics

mBio has been working on a low-cost, high-sensitivity medical diagnostic system to detect multiple pathogens, infectious diseases, and respiratory, cardiac and allergy complications. By reducing the need for lab work and lab instruments, mBio is hoping to supply medical professionals around the world with the mBio instrument.

Firm with CU roots ready with breast cancer test kit

University of Colorado scientist Jeff Holt and his research partner, Rita Lieberman discuss their company Tissue Genetics and the breast cancer kit that was recently developed.

Epsilon Securities, LLC, M&A advisor to MEDdevice Acquisition Co., LLC

Aurora, CO - MEDdevice Acquisition Corporation LLC (“MDAC”) is proud to announce that it has retained Epsilon Securities, LLC as M&A advisor in its focus to build a significant enterprise in one or more select medical device sectors of the medical device industry.

SIEMENS AND NATIONAL JEWISH MEDICAL AND RESEARCH CENTER FORM STRATEGIC ALLIANCE TO ADVANCE SHARED VISION OF PERSONALIZED MEDICINE

Malvern, Pa., and Denver, Colo., February 13, 2008 – With a shared vision of a more personalized medicine, Siemens Healthcare and National Jewish Medical and Research Center have formed a strategic alliance to improve and develop novel imaging and diagnostic technologies using genomics, proteomics, and integrated research and clinical care.

Aurora biotech firm gets more money

An Aurora biotech company that sprang from university research expects to receive as much as $65 million in Series B financing.

Solix Biofuels hopes to generate green from algae

Solix Biofuels Inc., based in Fort Collins and housed at Colorado State University, has spent a year sorting through 40 strains of algae collected from around the world. The startup, with 35 employees, seeks the best strains and best environment for the tiny organisms to live, grow, multiply and produce renewable, biologically based oil for diesel and jet fuel.

Baxa Corporation Launches Campaign to Recognize IV Nurse Day and Introduce the New PadLock(R) Set Saver

ENGLEWOOD, Colo., Jan. 25—Baxa Corporation announces the launch of a targeted campaign recognizing the dedication of infusion nurses to advancing the delivery of quality therapy to patients, promoting research and education in their practice and continually improving outcomes in patients receiving IV therapy.

Ernst & Young Seeks Rocky Mountain Region’s Exceptional Entrepreneurs

Denver, CO, January 24, 2008—Ernst & Young LLP today opened the nomination period for the Ernst & Young Entrepreneur Of The Year® 2008 Awards in the Rocky Mountain Region. The deadline for applications is Friday, March 28, 2008, with the awards ceremony scheduled for June 19, 2008 at the Belmar Center.

Pharmion wins approval for European sale of thalidomide

Pharmion Corp. won recommended approval to reintroduce the drug thalidomide to Europe, 45 years after its use by pregnant women caused thousands of jarring birth defects across the continent.

Array reaches deal with Celgene

Array BioPharma Inc. will receive an upfront payment of $40 million from a new collaboration agreement announced Monday.

Inviragen Wins 2007 Rising Star Company Award

Inviragen received the “Rising Star” company award given to the company that demonstrated the most potential in 2007 at the BioWest meeting today.